Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Altincatal

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
How Does Non-Malignant Opioid Induced Constipation (Oic) Impact Health State Utility?R Lawson, K Marsh, A Altincatal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Modelling Long-Term Changes In Opioid Induced Constipation (OIC)A Altincatal, R Lawson, F King, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosisS D Newsome, S Guo, A Altincatal, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
How Does Non-Malignant Opioid Induced Constipation (Oic) Impact Health State Utility?R Lawson, K Marsh, A Altincatal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Modelling Long-Term Changes In Opioid Induced Constipation (OIC)A Altincatal, R Lawson, F King, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosisS D Newsome, S Guo, A Altincatal, et al.
Pageof 1